Nanoparticle Wound Healing Treatment Patent US12599698B2
Summary
USPTO granted patent US12599698B2 to Kismet Technologies Inc. on April 14, 2026, covering a therapeutic article with metal-modified cerium oxide nanoparticles (mCNPs) for wound healing and antimicrobial infection control. The patent includes 19 claims for the nanoparticle-treated fiber composition with particles sized 3-35nm.
What changed
USPTO granted patent US12599698B2 to Kismet Technologies Inc. for a therapeutic article comprising fibers treated with metal-modified cerium oxide nanoparticles (mCNPs) sized 3-35nm, mixed at 0.01-0.1 weight percentage with polymeric binder, dispersant, and/or stabilizer. The patent covers wound healing applications and antimicrobial infection control barriers.
The grant provides Kismet Technologies Inc. with exclusive IP rights to this nanoparticle wound treatment technology in the US market. Competitors developing similar nanoparticle wound healing products will need to either license the technology or design around the patent claims.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control
Grant US12599698B2 Kind: B2 Apr 14, 2026
Assignee
Kismet Technologies Inc.
Inventors
Christina H. Drake
Abstract
A therapeutic article of manufacture that includes a body having fibers treated with a mixture including metal-modified cerium oxide nanoparticles (mCNPs) and one or more of a polymeric binder, a dispersant and a stabilizer. The mCNPs have a predominant 3+ surface charge and in a range of about 3-35 nanometers (nm) in size. The mCNPs are mixed in an amount that is in a range of about 0.01 to 0.1 weight percentage of the mixture having the mCNPs and the one or more of a polymeric binder, a dispersant and a stabilizer. The metal (m) is an antimicrobial promoting metal that is non-ionizing. A method is also provided that promotes wound healing and/or antimicrobial infection control with a barrier of the therapeutic article of manufacture.
CPC Classifications
A61K 33/00 A61K 9/14 A61K 9/0014 B82Y 30/00
Filing Date
2022-10-26
Application No.
17973769
Claims
19
Related changes
Get daily alerts for USPTO Patent Grants - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.